OCI Partners (NYSE: OCIP) is one of 46 public companies in the “Specialty Chemicals” industry, but how does it contrast to its competitors? We will compare OCI Partners to similar businesses based on the strength of its valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.

Earnings & Valuation

This table compares OCI Partners and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
OCI Partners $258.23 million -$50.55 million -99.99
OCI Partners Competitors $1.91 billion $115.75 million 236.62

OCI Partners’ competitors have higher revenue and earnings than OCI Partners. OCI Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.


This table compares OCI Partners and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OCI Partners -1.79% -3.70% -0.86%
OCI Partners Competitors -6.63% -0.18% 3.71%

Risk and Volatility

OCI Partners has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, OCI Partners’ competitors have a beta of 1.43, meaning that their average share price is 43% more volatile than the S&P 500.


OCI Partners pays an annual dividend of $0.48 per share and has a dividend yield of 6.9%. OCI Partners pays out -685.6% of its earnings in the form of a dividend. As a group, “Specialty Chemicals” companies pay a dividend yield of 1.3% and pay out 26.3% of their earnings in the form of a dividend. OCI Partners is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Analyst Ratings

This is a summary of recent ratings for OCI Partners and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OCI Partners 1 0 0 0 1.00
OCI Partners Competitors 170 1049 1310 24 2.47

OCI Partners presently has a consensus target price of $7.00, suggesting a potential upside of 0.00%. As a group, “Specialty Chemicals” companies have a potential downside of 2.26%. Given OCI Partners’ higher possible upside, equities research analysts plainly believe OCI Partners is more favorable than its competitors.

Institutional & Insider Ownership

15.0% of OCI Partners shares are held by institutional investors. Comparatively, 66.2% of shares of all “Specialty Chemicals” companies are held by institutional investors. 7.5% of shares of all “Specialty Chemicals” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.


OCI Partners competitors beat OCI Partners on 10 of the 14 factors compared.

OCI Partners Company Profile

OCI Partners LP owns and operates an integrated methanol and ammonia production facility that is located on the Texas Gulf Coast near Beaumont. The Company has an annual methanol production capacity of approximately 912,500 metric tons and an annual ammonia production capacity of approximately 331,000 metric tons. It purchases natural gas from third parties and processes the natural gas into synthesis gas, which it then further processes in the production of methanol and ammonia. It stores and sells the processed methanol and ammonia to industrial and commercial customers for further processing or distribution. Its methanol production unit comprises Foster-Wheeler-designed twin steam methane reformers for synthesis gas production, over two Lurgi-designed parallel low-pressure, water-cooled reactors and approximately four distillation columns. The Haldor-Topsoe-designed ammonia synthesis loop at its facility processes hydrogen produced by methanol production process.

Receive News & Stock Ratings for OCI Partners LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OCI Partners LP and related stocks with our FREE daily email newsletter.